#TBT to the #TLM25 Women’s Networking Luncheon, all seven of AASLD’s past female presidents came together for a truly inspiring moment: honoring a legacy of leadership that continues to shape the field of #hepatology.

Are you caught up on the latest developments in rare liver disorders?

See the updates from #TLM25, including our expert round-ups, here: go.sn.pub/63rlnl

#AASLD President Saul Karpen speaking at The Best of #TLM25: AASLD & Saudi Society for the Study of Liver Diseases at the #SASLT Conference 2026 in Riyadh, Saudi Arabia.

⏰ Last chance #TLM25 attendees! Tomorrow is the final day to claim your CME credits and access all the sessions on TLMdX.

Claim your credits here: https://bit.ly/3ZLRPLw
Revisit sessions here: https://bit.ly/4ofhHK1

#Hepatology #MedicalInnovation #LiverResearch

It’s the people who make #TLM25 unforgettable! Looking back at the conversations, collaborations, and shared discoveries, we’re reminded of the incredible power of our global hepatology community.

#HepatologyCommunity #LiverDoctors

Don’t forget to claim your CME credits for the sessions you completed at #TLM25! Visit the link and complete your submission by December 31. https://bit.ly/3ZLRPLw

#Hepatology #LiverResearch

🎥 Dr. Cecilia Dueñas Fryckman, CEO of the PBC Research Foundation, shares her story with Vera Luxner, Director of Advocacy at RDA, at @aasldnews.bsky.social The Liver Meeting (#TLM25)

Find out more about the PBC Research Foundation: https://bit.ly/4qgHXoY

#RareAdvocacySpotlight #RareDisease

Reflecting back on the energy and discoveries shared in the #TLM25 Poster Hall. 💡

Ready to step into the spotlight next year? The 2026 Call for Abstracts opens in March! Subscribe to our email list to get the latest TLM updates and stay tuned. https://bit.ly/48QwZPS

#Hepatology #ClinicalResearch

Experts, patients, and innovators all in one place! @kiwell.nutrition shared her Day 1 recap from #TLM25, highlighting the sessions she attended and the ones she’s planning to dive into next.

🎥 @kiwell.nutrition

#Hepatology #LiverHealth #GlobalLiverCommunity

Scrolling through your #TLM25 pics like… 😍

#Hepatology #HepatologyCommunity #GlobalLiverCommunity

Miss a moment at #TLM25? You can now stream the sessions on TLMdX! Tap the link to access session recordings and keep the learning going. eppro01.ativ.me/web/index.php

#Hepatology #MedicalInnovation #LiverResearch

AASLD’s The Liver Meeting 2025: Highlights from #TLM25 Discover key insights, research updates, and highlights from AASLD’s The Liver Meeting 2025 (#TLM25) in Washington, D.C.

🎉 #TLM25 Recap

From Nov 7–11, leaders in #Hepatology met in D.C. for @aasldnews.bsky.social's annual The Liver Meeting, sharing key research, patient insights, and innovations in care.

Catch Rare Disease Advisor’s top highlights ➡️ https://bit.ly/4axf17f

#RareDisease #LiverDisease #MedSky

The #TLM25 photo gallery is now live! Explore, share, and relive all your favorite moments from this year’s meeting. www.flickr.com/photos/aasld/collections...

#Hepatology #HepatologyCommunity

Here’s a snapshot at the impact we made at #TLM25, together — advancing research, education, and the future of hepatology. 💪

#HepatologyCommunity #MedicalInnovation #LiverResearch

Seladelpar Eases PBC-Related Itch for 30 Months Majority of patients achieve meaningful pruritus relief, according to long-term ASSURE data

"It's difficult to distinguish [between] the two ... fighting for that little bit of the top of the mountain." -- Andrew Mason, MBBS, discussing seladelpar and elafibranor for pruritus relief in primary biliary cholangitis. #TLM25 @aasldnews.bsky.social
www.medpagetoday.com/meetingcover...

Blood Test May Be a 'Viable Alternative' in Liver Cancer Surveillance Investigational multi-target test more sensitive than ultrasound, but fell short in specificity

An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting early hepatocellular carcinoma (HCC), according to a prospective study. #TLM25
www.medpagetoday.com/meetingcover...

Seladelpar Eases PBC-Related Itch for 30 Months Majority of patients achieve meaningful pruritus relief, according to long-term ASSURE data

Seladelpar (Livdelzi) provided sustained pruritus relief for up to 30 months in patients with primary biliary cholangitis (PBC), according to long-term data from the open-label ASSURE study. #TLM25
www.medpagetoday.com/meetingcover...

After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk Patients with liver fibrosis FIB-4 scores of 1.45 or more were at significantly greater risk

Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from Japan. #TLM25
www.medpagetoday.com/meetingcover...

Falls Drop Sharply With Lactulose, Tai Chi Combo in Cirrhosis Trial Dual intervention outperformed usual care in reducing falls, injury risk

A dual intervention using lactulose and virtual tai chi significantly reduced falls and related harms in patients with cirrhosis and portal hypertension, according to results from the LIVE-SMART trial. #TLM25 www.medpagetoday.com/meetingcover...

Such a pleasure to meet Dr Grace Su ( #AASLD President ) & to connect with Dr Saul Karpen ( #AASLD President-Elect ) at #TLM25 Day 5!!
I so enjoyed attending my first Liver Meeting—it was terrific!!
@childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy

What an inspiring moment at the #TLM25 Women's Networking Luncheon where all seven #AASLD female presidents stood together. Attendees shared how meaningful it was to see this legacy of leadership in one room.

What an incredible week! 🙌 Thank you to everyone who joined us for #TLM25 and helped make it a success.

Save the date for #TLM26 in Denver, November 5–9, 2026. See you next year!

⏪ Monday Rewind ⏪
Monday was all about making connections that matter. From hallway conversations to new collaborations, #TLM25 continued to bring the liver community together — here’s to a strong finish on the final day! 🤝

A big thank you to our incredible sponsors! 🌟 Your support fuels the research, education, and connections that push hepatology forward. #TLM25

As #TLM25 comes to a close, today’s Debrief and Late-Breaking Oral Abstracts capture the science and insights from the meeting.

Thank you to all who joined us in advancing hepatology through research, collaboration, and shared purpose!

My step count always spikes during academic meetings 🙃‼️
Day 4 👟👟 #TLM25
@childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy

😬😂 #TLM25 @childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy

PBC Associated With Increased and Earlier Risk of Bone Fractures Patients with PBC had more fractures per patient and earlier fracture onset after 65 years of age than controls without liver disease.

#TLM25: Primary biliary cholangitis (#PBC) is associated with a significantly increased and earlier risk of #BoneFractures compared to postmenopausal controls. Presented at @aasldnews.bsky.social The Liver Meeting 2025 by researchers of @clevelandclinic.bsky.social

Read more https://bit.ly/4p85Yhn

Missing @aasldnews.bsky.social's annual meeting?
No worries -- we're covering all the highlights from #TLM25 here at MedPage Today. Catch up ⬇️